SHINE trial sheds light on deadly stroke complication (IMAGE)

University of Virginia Health System

SHINE trial sheds light on deadly stroke complication

Caption

The new analysis of the trial results, led by UVA Health’s Andrew Southerland, MD, found that high blood sugar shortly after thrombolysis – opening blocked arteries in the brain with a clot-busting drug – was associated with greater risk for potentially deadly brain bleeds, particularly in older patients with more severe strokes.

Credit

UVA Health

Usage Restrictions

May be used to accompany news coverage of the SHINE trial findings. All other uses require express written permission from UVA Health.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.